Hypha Labs, Inc. (FUNI)
OTCMKTS · Delayed Price · Currency is USD
0.0250
-0.0019 (-7.06%)
Sep 15, 2025, 3:54 PM EDT
Hypha Labs Market Cap
Hypha Labs has a market cap or net worth of $3.61 million as of September 17, 2025. Its market cap has increased by 129.00% in one year.
Market Cap
3.61M
Enterprise Value
5.32M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since June 20, 2012, Hypha Labs's market cap has decreased from 5.53M to 3.61M, a decrease of -34.67%. That is a compound annual growth rate of -3.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 3.63M | -4.06% |
| Dec 31, 2024 | 3.78M | 8.54% |
| Dec 29, 2023 | 3.48M | 479.90% |
| Dec 30, 2022 | 600.77K | -70.87% |
| Dec 31, 2021 | 2.06M | 57.32% |
| Dec 31, 2020 | 1.31M | -69.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 782.91M |
| Elite Pharmaceuticals | 735.19M |
| Glass House Brands | 548.40M |
| Northwest Biotherapeutics | 379.14M |
| American Oncology Network | 353.52M |
| CytoDyn | 351.92M |